Empower Clinics Names Carolyn Shields as SVP of Operations of Its Integrated Healthcare Clinics
Seasoned executive with more than 20 years of professional medical practice management to lead ongoing success and expansion of The...
Staff
Stereotaxis to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for...
TransCode Therapeutics Announces Expansion of Global RNA Oncology Patent Portfolio
BOSTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer...
Teclison Completes $5.9 Million Capital Raise
Led by W.T.T. Investment, the family office of Taiwan’s Tsai familyProceeds to Advance Clinical Studies of its Potential First-in-Class Therapeutic...
POINT Biopharma Provides Early-Stage Program Updates
Phase 1 therapeutic trial for PNT6555, the lead of the pan-cancer PNT2004 fibroblast activation protein-alpha (FAP-alpha) inhibitor program, planned for...
Veru Reports that Independent Data Monitoring Committee for the Phase 3 Sabizabulin COVID-19 Clinical Study Recommends Continuing Study as Planned
--Planned Conditional Statistical Power Analysis was Conducted— --Primary Efficacy Study Endpoint Is Proportion of Patients that Die on Study Up...
Albireo Announces Publication of the PICTURE Study Highlighting the Caregiver Impact of PFIC, a Rare and Devastating Children’s Liver Disease
PFIC caregivers reported high impact on mental and physical health, productivity, career prospects, sleep, relationships and financesStudy suggests PFIC caregivers’...
BioCorRx Announces Orange County Research Center as Clinical Trial Site for First-In-Human Clinical Trial of BICX104
ANAHEIM, CA, Feb. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
Britannia to Launch Hair Growth Trial Utilizing CBD Formulation
London, United Kingdom and Toronto, Ontario--(Newsfile Corp. - February 14, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia"), a...
Green Shield Canada’s Claim Watch to Participate in Data Pooling to Reduce Benefits Fraud
Toronto, Ontario--(Newsfile Corp. - February 14, 2022) - Green Shield Canada (GSC),and its Claim Watch fraud investigation team are joining...
Forbes Names Philips a Top Place to Work in “America’s Best Employers of 2022” Ranking
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the company has once...
PriorAuthNow Raises $25 Million to Expedite Healthcare Authorizations
Funding round is led by Insight Partners to accelerate growth and fuel platform’s network expansion to meet surging demand COLUMBUS,...
Imperative Care Announces the Launch of Its Zoom POD™ for Stroke Treatment, the First and Only Filter to Capture Clot in the Sterile Field
Newest addition to company’s Zoom Stroke Solution allows for quick confirmation of successful clot retrieval during mechanical thrombectomy for ischemic...
450 of the Latest Dosell Produced and Delivered to Partners
STOCKHOLM, SWEDEN / ACCESSWIRE / February 14, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group AB (publ.) - announces that since the...
AB Science – Clarification following the February 11, 2022 public hearing of the Enforcement Committee of the French Market Regulator (AMF)
PRESS RELEASE CLARIFICATION FOLLOWING THE FEBRUARY 11, 2022 PUBLIC HEARING OF THE ENFORCEMENT COMMITTEE OF THE FRENCH MARKET REGULATOR (AMF)...
Pharma-Bio Serv Announces Full Year Results and Declares a Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / February 11, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a...
Boosh Acquires Beanfields
Vancouver, British Columbia--(Newsfile Corp. - February 11, 2022) - Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77i) ("Boosh" or...
Canadian School Counselling Week 2022: Who We Are and How We Help
Ottawa, Ontario--(Newsfile Corp. - February 11, 2022) - As students across Canada return to in-person schooling during another school year...
NLS Pharmaceutics to Participate in 2022 BIO CEO & Investor Conference
ZURICH, SWITZERLAND / ACCESSWIRE / February 11, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
After Three Years of Record Growth, Beam Continues Expansion with First Chief Product Officer
Fintech and digital health veteran brings two decades of experience building and scaling digital products.COLUMBUS, Ohio, Feb. 11, 2022 (GLOBE...